IL‐13 modulates ∆Np63 levels causing altered expression of barrier‐ and inflammation‐related molecules in human keratinocytes: A possible explanation for chronicity of atopic dermatitis
Authors:
Open Access
- 1 April 2021
- journal article
- research article
- Published by Wiley in Immunity, Inflammation and Disease
- Vol. 9 (3) , 734-745
Abstract
Background: Barrier disruption and an excessive immune response in keratinocytes are now considered to have important roles in the pathophysiology of atopic dermatitis (AD). Furthermore, disturbed keratinocyte differentiation is considered to underlie AD. ΔNp63, a p53‐like transcription factor, is a major regulator of keratinocyte differentiation. However, the functional significance of ΔNp63 in AD has not been clarified.Objective: In this study, we aimed to investigate the influence of the type 2 inflammatory environment on ΔNp63 expression and AD‐associated molecules regulated by ΔNp63 in keratinocytes.Methods: The immunohistochemical expression profiles of ΔNp63 and AD‐related molecules were evaluated in human skin tissue. The function of ΔNp63 in the regulation of AD‐related molecules and the influence of the type 2 inflammatory environment on ΔNp63 expression were investigated using human primary keratinocytes. Expression of ΔNp63 was manipulated using the RNA interfering method.Results: In healthy skin tissue, we observed an inverse expression pattern between ∆Np63 and some barrier‐related proteins including filaggrin, caspase‐14, claudin‐1, and claudin‐4. ΔNp63 regulated expression of these genes and proteins. In addition, production of IL‐1β and IL‐33, pro‐inflammatory cytokines, was modulated by ΔNp63. Furthermore, prolonged IL‐13 exposure increased the thickness of the three‐dimensional culture of keratinocytes. IL‐13 interfered with ΔNp63 downregulation during calcium‐induced keratinocyte differentiation. IL‐13 modulated some barrier‐related and inflammation‐related molecules, which were regulated by ΔNp63.Conclusions: We have shown that ΔNp63 modulated AD‐related barrier and inflammatory molecules. In addition, ΔNp63 expression was affected by IL‐4/IL‐13. IL‐13–ΔNp63 axis would integrate two major factors of AD pathogenesis: dysregulated barrier and inflammation.Keywords
Funding Information
- Japan Society for the Promotion of Science (19K16562)
- Akiyama Life Science Foundation
This publication has 50 references indexed in Scilit:
- The role of IL-22 and Th22 cells in human skin diseasesJournal of Dermatological Science, 2013
- Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitisJournal of Allergy and Clinical Immunology, 2012
- p63–microRNA feedback in keratinocyte senescenceProceedings of the National Academy of Sciences, 2012
- Regulation of caspase 14 expression in keratinocytes by inflammatory cytokines - a possible link between reduced skin barrier function and inflammation?Experimental Dermatology, 2011
- Role of p63/p73 in epithelial remodeling and their response to steroid treatment in nasal polyposisJournal of Allergy and Clinical Immunology, 2011
- Tight junction defects in patients with atopic dermatitisJournal of Allergy and Clinical Immunology, 2011
- Comparative proteomic profiling of patients with atopic dermatitis based on history of eczema herpeticum infection and Staphylococcus aureus colonizationJournal of Allergy and Clinical Immunology, 2011
- p63 induces key target genes required for epidermal morphogenesisProceedings of the National Academy of Sciences, 2007
- ΔNp63α functions as both a positive and a negative transcriptional regulator and blocks in vitro differentiation of murine keratinocytesOncogene, 2003
- Retinoic Acid Inhibits Downregulation of ΔNp63α Expression During Terminal Differentiation of Human Primary KeratinocytesJournal of Investigative Dermatology, 2002